PATENT CLAIM ANALYSIS

Application Number: 16320723
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "263200"]

Abstract:
The invention relates to a xanthine derivative defined by chemical formula I or a salt thereof, its use as a medicament, especially for use in the treatment of serotonin-related diseases or disorders, and a pharmaceutical preparation comprising the xanthine derivative. The novel xanthine compounds are capable of inhibiting tryptophan hydroxylases (TPH) involved in the biosynthesis of serotonin and are effective in influencing the serotonin level in the body.

Claim (Index 11):
Xanthine derivative according to  claim 1 , wherein the treatment of serotonin-related diseases or disorders.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 99.0
- Lexical Diversity: 1.47059
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15552556', '13389993', '12474838', '09738376', '11542166']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8144871084416582
- 35 USC 102 Novelty (BERT): 0.5842301580497589
- Combined Prediction Score: 0.7914614134024682
- Mean Citation Score: 385.525688
- Max Citation Score: 580.3537
- Similarity Product: 379.9836040941

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test